임신 중 imidazolidinone을 피해야 할까요? | VeriMom
Animal reproduction data (multi‑generation / reproductive studies) report effects (reports / summaries cite reduced litter weights and reproductive NOAELs), and multiple safety data sheets / C&L inventory notifications list Repr.2 / H361 for 2‑imidazolidinone; however there is no harmonised CLH (no ECHA Annex VI H360) nor a formal CIR/SCCS opinion specific to CAS 120‑93‑4. Taken together this supports ‘suspected’ (h=2) but not confirmed teratogen status. (sources: ECHA substance pages / C&L notifications; literature summary of reproductive studies).
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- imidazolidinone은 임신 중 안전한가요?
- Animal reproduction data (multi‑generation / reproductive studies) report effects (reports / summaries cite reduced litter weights and reproductive NOAELs), and multiple safety data sheets / C&L inventory notifications list Repr.2 / H361 for 2‑imidazolidinone; however there is no harmonised CLH (no ECHA Annex VI H360) nor a formal CIR/SCCS opinion specific to CAS 120‑93‑4. Taken together this supports ‘suspected’ (h=2) but not confirmed teratogen status. (sources: ECHA substance pages / C&L notifications; literature summary of reproductive studies).
- imidazolidinone은 모유 수유 중 안전한가요?
- Same basis as pregnancy: animal reproduction findings and multiple supplier/SDS / C&L inventory notifications raising Repr.2 (H361) support a cautious classification of ‘suspected’ reproductive hazard. Direct data on lactational transfer or human breastfeeding outcomes were not located. Exposure via cosmetics expected to be low. (sources: supplier SDS / C&L notifications; literature summaries).
- imidazolidinone은 아기 피부에 안전한가요?
- Hazard (h=2) carried over from animal reproductive effects and H361 notifications. No infant‑specific studies were found. Dermal exposure assessment/data (dermal absorption rates in adults or infants) were not located — cosmetic exposure is likely low so exposure score remains 0; infant dermal absorption was not demonstrably quantified in available sources. (sources: SDS / C&L inventory; literature summaries).
- VeriMom은 imidazolidinone을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 imidazolidinone을 39/100 (높은 위험)로 평가합니다.
- 임신 중 imidazolidinone 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.